Press Release
September 13, 2023

Lauxera Capital Partners Invests €17 Million in BioLamina

The Life Sciences team advised Lauxera Capital Partners on the intellectual property aspects of its €17 million investment in BioLamina AB.

Founded in January 2020, Lauxera Capital Partners is an independent asset management company based in Paris, France and in San Francisco, California.

BioLamina is a biotechnology company with a scientific base and heritage in matrix biology and cell culture research.

The Goodwin team included Duncan Greenhalgh, Lily Xu, and Pamela Johnson.

For more details, read the press release.